- Home
- NURO vs EVAX Comparison
NURO vs EVAX Comparison
Compare NURO & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NURO
- EVAX
- Stock Information
- Founded
- NURO 1996
- EVAX 2008
- Country
- NURO United States
- EVAX Denmark
- Employees
- NURO N/A
- EVAX N/A
- Industry
- NURO Medical/Dental Instruments
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NURO Health Care
- EVAX Health Care
- Exchange
- NURO Nasdaq
- EVAX Nasdaq
- Market Cap
- NURO 7.6M
- EVAX 8.7M
- IPO Year
- NURO N/A
- EVAX 2021
- Fundamental
- Price
- NURO $3.86
- EVAX $0.88
- Analyst Decision
- NURO
- EVAX Strong Buy
- Analyst Count
- NURO 0
- EVAX 2
- Target Price
- NURO N/A
- EVAX $11.00
- AVG Volume (30 Days)
- NURO 23.4K
- EVAX 77.4K
- Earning Date
- NURO 11-05-2024
- EVAX 10-31-2024
- Dividend Yield
- NURO N/A
- EVAX N/A
- EPS Growth
- NURO N/A
- EVAX N/A
- EPS
- NURO N/A
- EVAX N/A
- Revenue
- NURO $3,767,764.00
- EVAX $3,295,000.00
- Revenue This Year
- NURO N/A
- EVAX $4,845.21
- Revenue Next Year
- NURO N/A
- EVAX $30.30
- P/E Ratio
- NURO N/A
- EVAX N/A
- Revenue Growth
- NURO N/A
- EVAX N/A
- 52 Week Low
- NURO $2.66
- EVAX $0.87
- 52 Week High
- NURO $4.73
- EVAX $13.61
- Technical
- Relative Strength Index (RSI)
- NURO 51.55
- EVAX 19.35
- Support Level
- NURO $3.63
- EVAX $1.08
- Resistance Level
- NURO $4.07
- EVAX $1.20
- Average True Range (ATR)
- NURO 0.24
- EVAX 0.18
- MACD
- NURO -0.03
- EVAX -0.01
- Stochastic Oscillator
- NURO 56.09
- EVAX 1.11
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.
About EVAX Evaxion Biotech A/S
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.